BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21361438)

  • 1. Effects of aspirin on distortion product fine structure: interpreted by the two-source model for distortion product otoacoustic emissions generation.
    Rao A; Long GR
    J Acoust Soc Am; 2011 Feb; 129(2):792-800. PubMed ID: 21361438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring distortion product otoacoustic emissions using continuously sweeping primaries.
    Long GR; Talmadge CL; Lee J
    J Acoust Soc Am; 2008 Sep; 124(3):1613-26. PubMed ID: 19045653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of aspirin on phase gradient of 2F1-F2 distortion product otoacoustic emissions.
    Parazzini M; Hall AJ; Lutman ME; Kapadia S
    Hear Res; 2005 Jul; 205(1-2):44-52. PubMed ID: 15953514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extraction of sources of distortion product otoacoustic emissions by onset-decomposition.
    Vetesník A; Turcanu D; Dalhoff E; Gummer AW
    Hear Res; 2009 Oct; 256(1-2):21-38. PubMed ID: 19523509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ototoxicity risk assessment combining distortion product otoacoustic emissions with a cisplatin dose model.
    Dille MF; McMillan GP; Reavis KM; Jacobs P; Fausti SA; Konrad-Martin D
    J Acoust Soc Am; 2010 Sep; 128(3):1163-74. PubMed ID: 20815453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
    Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cochlear nonlinearity in normal-hearing subjects as inferred psychophysically and from distortion-product otoacoustic emissions.
    Johannesen PT; Lopez-Poveda EA
    J Acoust Soc Am; 2008 Oct; 124(4):2149-63. PubMed ID: 19062855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Level dependence of the nonlinear-distortion component of distortion-product otoacoustic emissions in humans.
    Zelle D; Thiericke JP; Dalhoff E; Gummer AW
    J Acoust Soc Am; 2015 Dec; 138(6):3475-90. PubMed ID: 26723305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olivocochlear reflex effect on human distortion product otoacoustic emissions is largest at frequencies with distinct fine structure dips.
    Wagner W; Heppelmann G; Müller J; Janssen T; Zenner HP
    Hear Res; 2007 Jan; 223(1-2):83-92. PubMed ID: 17137736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distortion-product otoacoustic emissions and cochlear microphonics: relationships in patients with and without endolymphatic hydrops.
    Fetterman BL
    Laryngoscope; 2001 Jun; 111(6):946-54. PubMed ID: 11404602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Observations of Distortion Product Otoacoustic Emission Components in Adults With Hearing Loss.
    Prieve BA; Thomas L; Long G; Talmadge C
    Ear Hear; 2020; 41(3):652-662. PubMed ID: 31569117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sources and mechanisms of DPOAE generation: implications for the prediction of auditory sensitivity.
    Shaffer LA; Withnell RH; Dhar S; Lilly DJ; Goodman SS; Harmon KM
    Ear Hear; 2003 Oct; 24(5):367-79. PubMed ID: 14534408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for the distortion product frequency place as a source of distortion product otoacoustic emission (DPOAE) fine structure in humans. I. Fine structure and higher-order DPOAE as a function of the frequency ratio f2/f1.
    Mauermann M; Uppenkamp S; van Hengel PW; Kollmeier B
    J Acoust Soc Am; 1999 Dec; 106(6):3473-83. PubMed ID: 10615687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for the distortion product frequency place as a source of distortion product otoacoustic emission (DPOAE) fine structure in humans. II. Fine structure for different shapes of cochlear hearing loss.
    Mauermann M; Uppenkamp S; van Hengel PW; Kollmeier B
    J Acoust Soc Am; 1999 Dec; 106(6):3484-91. PubMed ID: 10615688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies of the evaluation of cochlea function with distortion product otoacoustic emission].
    Kashiwamura M
    Hokkaido Igaku Zasshi; 1998 Nov; 73(6):641-62. PubMed ID: 10036620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in amplitude and phase of distortion-product otoacoustic emission fine-structure and separated components during efferent activation.
    Henin S; Thompson S; Abdelrazeq S; Long GR
    J Acoust Soc Am; 2011 Apr; 129(4):2068-79. PubMed ID: 21476662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distortion product otoacoustic emission fine structure is responsible for variability of distortion product otoacoustic emission contralateral suppression.
    Sun XM
    J Acoust Soc Am; 2008 Jun; 123(6):4310-20. PubMed ID: 18537382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating the wave-fixed and place-fixed origins of the 2f(1)-f(2) distortion product otoacoustic emission within a micromechanical cochlear model.
    Young JA; Elliott SJ; Lineton B
    J Acoust Soc Am; 2012 Jun; 131(6):4699-709. PubMed ID: 22712943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery of distortion-product otoacoustic emissions after a 2-kHz monaural sound-exposure in humans: effects on fine structures.
    Aranda de Toro MA; Ordoñez R; Reuter K; Hammershøi D
    J Acoust Soc Am; 2010 Dec; 128(6):3568-76. PubMed ID: 21218889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexposure effects of a 1-kHz tone on the distortion product otoacoustic emission in humans.
    Reuter K; Ordoñez R; Hammershoi D
    J Acoust Soc Am; 2007 Jul; 122(1):378-86. PubMed ID: 17614497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.